Will Be Interesting To See How Tyvaso DPI (UTHR's) and Utrepia (Liquidia's) Eventually Compete | MNKD Message Board Posts


MannKind Corporation

  MNKD website

MNKD   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  17841 of 17860  at  8/12/2022 4:40:02 PM  by

tocentsworth

The following message was updated on 8/12/2022 4:42:50 PM.

Will Be Interesting To See How Tyvaso DPI (UTHR's) and Utrepia (Liquidia's) Eventually Compete

Don't know how they compare as products, but both are Trepostinil based inhaled dry powder compounds that are aimed at Pulmonary Arterial Hypertension. I believe that Tyvaso DPI also has an FDA approved second indication, as well. The Tyvaso name is well respected by physicians. I am not sure how many are familiar with Utrepia. UTHR seems very high about the future prospects for Tyvaso DPI. Any other comments?
 
 
 
 
 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board




Financial Market Data provided by
.
Loading...